Mito-ATTEC Technology Development

Mito-ATTEC technology is a mitochondria-oriented Autophagy-Tethering Compound strategy designed to promote selective mitochondrial clearance by directly bringing mitochondria into proximity with autophagosomal machinery. A typical Mito-ATTEC molecule contains a mitochondria-targeting ligand, a microtubule-associated protein 1A/1B-light chain 3/gamma-aminobutyric acid receptor-associated protein (LC3/GABARAP)-binding module, and a linker that determines molecular reach, exposure, polarity, rigidity, and spatial orientation. Unlike AUTAC approaches that rely on autophagy-recognition signals such as K63-linked ubiquitination, Mito-ATTEC designs are built around target-to-autophagosome tethering and LC3-associated mitophagy engagement.

BOC Sciences provides integrated Mito-ATTEC technology development services for pharmaceutical, biotechnology, academic, and contract research organization (CRO) teams exploring mitochondrial degradation, mitophagy modulation, organelle quality control, cancer metabolism, and neurobiology-related mitochondrial dysfunction. Our support covers mitochondrial target feasibility assessment, mitochondria-targeting ligand selection, LC3/GABARAP-binding module evaluation, linker engineering, Mito-ATTEC synthesis, mitophagy assay development, mitochondrial function profiling, model validation, and iterative structure–activity optimization. For clients building broader autophagy-based degrader programs, our Mito-ATTEC platform can also be integrated with ATTEC degradation technology development to support target-specific and organelle-focused research strategies.

BOC Sciences' Comprehensive Mito-ATTEC Technology Development Services

Mitochondrial Target Feasibility and Strategy Assessment

A successful Mito-ATTEC project begins with a clear understanding of whether the selected mitochondrial phenotype, organelle population, or disease-relevant cellular state can be addressed by LC3-mediated autophagosome tethering. BOC Sciences evaluates mitochondrial biology, target accessibility, cellular context, autophagy competence, assay feasibility, and project-specific decision points before molecular design begins.

• Mitochondrial phenotype analysis: assessment of mitochondrial fragmentation, membrane-potential alteration, oxidative stress, metabolic vulnerability, organelle mass, and disease-relevant mitochondrial dysfunction
• Mitophagy pathway suitability: evaluation of basal autophagy activity, LC3 lipidation status, lysosomal function, autophagosome–lysosome fusion capacity, and model-dependent mitophagy responsiveness
• Targeting feasibility mapping: analysis of mitochondrial membrane accessibility, ligandable mitochondrial proteins, organelle enrichment potential, and the risk of nonspecific mitochondrial stress
• Assay strategy planning: definition of measurable endpoints such as TOM20, VDAC1, COX IV, LC3B-II, LAMP1 co-localization, mt-mKeima signal, ATP response, reactive oxygen species (ROS), and ΔΨ_m

Mitochondria-Targeting Ligand Design and Validation

The mitochondria-targeting module determines whether a Mito-ATTEC molecule can accumulate at the intended mitochondrial compartment while preserving enough spatial freedom for LC3 engagement. We support mitochondrial ligand selection, derivatization, exit-vector analysis, and validation to help clients build chemically practical and biologically interpretable Mito-ATTEC designs.

• Mitochondrial ligand selection: evaluation of mitochondria-associated scaffolds targeting outer mitochondrial membrane proteins, inner mitochondrial membrane environments, or mitochondrial-enriched chemical space
• Known ligand derivatization: structure-guided modification of mitochondrial ligands such as translocator protein (TSPO)-oriented scaffolds, triphenylphosphonium (TPP⁺)-based motifs, and other organelle-targeting chemotypes
• Exit-vector optimization: identification of conjugation positions that preserve mitochondrial association while allowing linker attachment and LC3-binding module presentation
• Subcellular localization validation: confirmation of mitochondrial enrichment using co-localization imaging, mitochondrial fractionation, and orthogonal subcellular distribution analysis

LC3/GABARAP-Binding Module Evaluation

Mito-ATTEC activity depends heavily on whether the autophagosome-binding module can engage LC3/GABARAP proteins under biologically relevant conditions. BOC Sciences supports LC3/GABARAP ligand assessment, binding validation, selectivity profiling, and functional compatibility analysis to reduce the risk of designing molecules around weak or misleading autophagy handles.

• LC3/GABARAP ligand screening: evaluation of small-molecule, fragment, or peptide-inspired LC3/GABARAP binders as potential autophagosome-recruiting modules
• Biophysical engagement validation: measurement of LC3/GABARAP interaction using methods such as fluorescence polarization, thermal shift analysis, nuclear magnetic resonance (NMR), isothermal titration calorimetry (ITC), or surface plasmon resonance (SPR)
• Binding pocket and selectivity analysis: assessment of LC3B, LC3A, GABARAP, GABARAPL1, and GABARAPL2 engagement profiles to support rational autophagy-recruitment design
• Autophagy compatibility assessment: investigation of whether the selected module supports productive autophagosome association without broadly blocking autophagy flux
• Integrated affinity support: clients can combine this module with binding affinity measurement services to compare LC3/GABARAP engagement across candidate modules

Linker Engineering for Productive Mitochondria–LC3 Tethering

Linker design is a decisive factor in Mito-ATTEC performance because the molecule must bridge a mitochondrial surface or membrane-associated ligand to LC3 on growing autophagosomal membranes. BOC Sciences builds focused linker design matrices that consider length, flexibility, polarity, rigidity, conformational bias, membrane permeability, and ternary interaction geometry.

• Linker length optimization: design of short, medium, and long linker series to evaluate the distance required for productive mitochondria–LC3 proximity
• PEG, alkyl, semi-rigid, and heterocyclic linkers: systematic comparison of linker chemotypes to balance solubility, mitochondrial access, cellular exposure, and spatial orientation
• Conjugation-site analysis: selection of attachment positions on both mitochondrial ligand and LC3-binding module to reduce steric conflict and maintain functional binding
• Structure-guided linker refinement: use of modeling and conformational assessment to prioritize analogs before synthesis
• Specialized linker support: our linker design and optimization services help clients translate early Mito-ATTEC concepts into focused, testable analog libraries

Mito-ATTEC Synthesis and Analog Generation

Mito-ATTEC molecules often require careful synthesis planning because they combine organelle-targeting motifs, LC3/GABARAP-binding modules, and linkers with distinct physicochemical properties. BOC Sciences provides custom Mito-ATTEC synthesis and analog generation to support early feasibility studies, structure–activity relationship exploration, and iterative optimization.

• Route design and synthetic feasibility review: evaluation of functional groups, conjugation sites, protecting-group strategies, and module compatibility
• Focused analog library generation: synthesis of Mito-ATTEC analogs with varied linker length, polarity, rigidity, attachment sites, and mitochondrial-targeting modules
• Control molecule design: preparation of negative-control analogs such as inactive LC3-binding variants, non-mitochondrial targeting controls, and linker-only comparators
• Compound characterization: structural confirmation using liquid chromatography–mass spectrometry (LC-MS), high-resolution mass spectrometry (HRMS), and NMR-based analysis
• Library expansion: integration with focused linker library resources for faster exploration of linker-driven activity trends

Mitophagy Validation and Functional Profiling

Mito-ATTEC validation requires more than measuring a reduction in mitochondrial markers. BOC Sciences develops multi-layered assay workflows to distinguish LC3-associated mitophagy from nonspecific mitochondrial damage, global autophagy activation, reduced mitochondrial biogenesis, or general cytotoxic stress.

• Mitochondrial marker quantification: Western blot, immunofluorescence, and flow cytometry analysis of TOM20, VDAC1, COX IV, TIM23, and mitochondrial DNA content
• Autophagosome and lysosome engagement: LC3B-II profiling, LC3 puncta analysis, LAMP1 co-localization, p62/SQSTM1 monitoring, and autophagy flux interpretation
• Mitophagy-specific reporter assays: mt-mKeima, tandem fluorescent mitochondrial reporters, and image-based quantification of mitochondria entering acidic compartments
• Mitochondrial function profiling: ATP measurement, ΔΨ_m analysis using JC-1 or TMRE, ROS detection, oxygen-consumption readouts, and mitochondrial morphology evaluation
• Degradation performance analysis: integration with degradation ability assay workflows to evaluate dose response, time dependence, D_max, and apparent DC₅₀

Our Solutions for Mito-ATTEC Development Challenges

Mito-ATTEC development requires the coordinated optimization of mitochondrial targeting, LC3/GABARAP engagement, linker geometry, cell-model context, autophagy flux, and mitochondrial function readouts. BOC Sciences helps clients convert uncertain organelle-degradation concepts into structured design–synthesis–validation programs with clear decision points.

Solution for LC3/GABARAP Engagement Uncertainty

Because LC3/GABARAP ligand validation is one of the most important risk points in ATTEC design, we do not assume that every reported autophagy handle will function in a Mito-ATTEC format. Our workflow combines biophysical binding analysis, competition assays, autophagy-marker profiling, and control analog design to determine whether the selected module can support meaningful autophagosome association.

Solution for Mitochondrial Ligand and Linker Integration

A strong mitochondrial ligand does not automatically create an effective Mito-ATTEC molecule. We evaluate ligand exit vectors, linker flexibility, linker length, charge distribution, molecular size, and LC3-binding module exposure together. This enables focused analog design rather than broad trial-and-error synthesis.

Solution for Mitophagy Assay Interpretation

Mitochondrial marker loss can result from selective mitophagy, mitochondrial injury, changes in mitochondrial biogenesis, or cell-state shifts. We build layered assay panels that combine TOM20, VDAC1, LC3, LAMP1, mt-mKeima, ΔΨ_m, ATP, ROS, and pathway-inhibition controls to clarify whether the observed phenotype reflects productive mitochondrial clearance.

Solution for Cellular Exposure and Developability Barriers

Mito-ATTEC molecules may show limited cellular activity if molecular size, charge, polarity, or membrane partitioning is poorly balanced. We evaluate solubility, cellular exposure, mitochondrial accumulation, permeability, and early stress markers together. Our cellular permeability assay support helps clients identify whether weak activity is caused by poor access, weak binding, or inadequate tethering geometry.

Our Mito-ATTEC Solutions Support Diverse R&D Organizations

End-to-End Mito-ATTEC Technology Development Workflow

Advantages of Mito-ATTEC Technology

Directly Engages Mitophagy Biology

Mito-ATTEC technology enables researchers to investigate mitochondrial clearance through LC3-associated autophagosome tethering, offering a chemical biology route to study mitophagy and organelle turnover.

Expands Beyond Proteasomal Degradation

Because mitochondria are organelles rather than conventional soluble proteasome substrates, Mito-ATTEC research expands targeted degradation into autophagy-lysosome biology and organelle-selective clearance.

Supports Ubiquitination-Independent Designs

Mito-ATTEC designs can be developed around mitochondria-to-LC3 proximity rather than E3 ligase recruitment or ubiquitin tagging, supporting alternative degradation logic for mitochondrial research.

Enables Structure-Guided Optimization

Systematic variation of mitochondrial ligand, LC3/GABARAP-binding module, linker length, and linker rigidity allows clients to understand how chemical structure influences mitophagy outcome.

Applications Supported by Our Mito-ATTEC Technology Platform

Client Success Stories: Mito-ATTEC Technology Development

Why Choose BOC Sciences for Your Mito-ATTEC Project?

Integrated Mito-ATTEC Development Support

We provide coordinated support across feasibility assessment, LC3/GABARAP-binding module evaluation, mitochondrial ligand strategy, linker engineering, synthesis, mitophagy assays, and optimization.

Deep Autophagy-Based Degrader Expertise

Our team understands the design logic of ATTEC and mitochondria-focused autophagy tethering, including LC3 engagement, linker orientation, organelle targeting, and mitophagy validation.

Mechanism-Focused Validation

We design studies that connect LC3 association, lysosomal delivery, mitochondrial marker reduction, autophagy flux, mitochondrial function, and pathway-control data.

Flexible Modular Service Models

Clients can access individual modules, such as LC3-binding module validation or linker optimization, or request end-to-end Mito-ATTEC development from concept to optimized analog series.

Data-Driven Design Iteration

We connect chemistry and biology data to refine mitochondrial ligands, LC3/GABARAP modules, linker properties, cell models, and assay conditions through rational optimization cycles.

Clear Reporting and Decision Support

We provide organized experimental data, practical interpretation, and clear recommendations to support the next stage of Mito-ATTEC design, screening, or validation.